Concurrent Oral 1 - Therapy of rheumatic disease: OP4. Effectiveness of Rituximab in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register (BSRBR)
Year: 2011
Type: article
Study design: Observational Study
Source: Rheumatology
Authors: M. M. Soliman, D. M. Ashcroft, K. D. Watson, M. Lunt, D. Symmons, K. L. Hyrich, H. J. Lachmann, P. Quartier, E. Hachulla, M. Gattorno, R. Cartwright, I. Kone-Paut, F. Zulian, E. Weisbarth-Riedel, L. Lepore, J. Hoyer, I. Foeldvari, E. Ramos, K. Leslie, G. Krammer, R. Preiss, E. Incera, J. B. Kuemmerle-Deschner, P. N. Hawkins, A. So, M. De Meulemeester, A. Pikhlak, A. E. Yucel, B. Bodalia, J. Kerrane, U. Arulmani, D. Richard, V. Murphy, P. Sallstig, N. Schlesinger, D. Christidis, N. Hassan, S. Mapplebeck, B. Dasgupta, M. C. Genovese, A. Sebba, A. Rubbert-Roth, J. Scali, M. Zilberstein, E. ` Vernon, R. Vollenhoven, E. Choy, B. White-Alao, F. Ibrahim, A. Kowalczyk, P. Gordon, A. Hakim, G. Kitas, D. Isenberg, B. Griffiths, B. Lecky, K. Chakravarty, J. Winer, K. Danko, R. G. Cooper, D. L. Scott
Institutions: University of Manchester, The Royal Free Hospital, University College London, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Université Paris Descartes, Arthritis Research UK, Hôpital Claude Huriez, Istituto Giannina Gaslini, Bicêtre Hospital, University of Padua, University Medical Center Hamburg-Eppendorf, IRCCS Materno Infantile Burlo Garofolo, Novartis (Switzerland), University of California, San Francisco, Universitätsklinikum Gießen und Marburg, Universitätsklinikum Tübingen, University of California San Francisco Medical Center, Novartis (United States), University Children's Hospital Tübingen, Hospital Universitario Central de Asturias
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2091629131